ArticleFrontiers in medicine2025
Histopathological characterization of inflammatory interparietal involvement in frontal fibrosing alopecia.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Frontal fibrosing alopecia (FFA) may involve the interparietal area; however, histopathologic features in this site remain undefined. Objective: The objective of the study was to histopathologically characterize inflammatory interparietal involvement in patients with FFA in real-world practice. Methods: A descriptive, retrospective study enrolled patients with FFA who developed interparietal inflammatory findings. Patients underwent two interparietal biopsies; samples were assessed under a uniform protocol, which included follicular counts, inflammatory infiltrate features, scar tissue, vacuolar degeneration (VD) of the follicular epithelium, epithelial or stromal (E/S) clefting, concentric lamellar fibroplasia (CLF), and sebaceous glands (SGs). Results: A total of 12 females (mean age: 64.25 years) were included. Following dermatopathologic review, six patients were classified as having crown-area FFA (CA-FFA), four patients as having fibrosing alopecia with a pattern distribution (FAPD), and two patients as having indeterminate cicatricial alopecia. CA-FFA showed greater structural loss with scar tissue and sebaceous gland reduction, whereas FAPD showed a miniaturization-dominant profile and increased catagen/telogen hairs. Patients with a biopsy suggestive of CA-FFA more often had a diffuse clinical pattern, were older, had a longer disease duration, and had approximately twice as much occipital involvement than as those in the FAPD group. Discussion/Conclusion: Given that FFA produces greater structural disruption than FAPD, our results raise the question of whether these conditions are overlapping entities or part of the same process that has progressed. Further studies in patients with FFA and FAPD are needed to elucidate the role of androgenetic factors in addition to lymphohistiocytic infiltrate and perifollicular lamellar fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.